AstraZeneca and CSPC join forces to combat high cholesterol
In a move to strengthen its cardiovascular treatment portfolio, AstraZeneca announced a partnership with CSPC Pharmaceutical Group that could reach a staggering $1.92 billion. This [more…]
In a move to strengthen its cardiovascular treatment portfolio, AstraZeneca announced a partnership with CSPC Pharmaceutical Group that could reach a staggering $1.92 billion. This [more…]
In a significant development, GlaxoSmithKline (GSK) announced promising results from a late-stage clinical trial for their vaccine, Arexvy, which exhibits the potential to protect adults [more…]
Biowearables represent a cutting-edge revolution in healthcare technology. These innovative devices are designed to monitor various physiological parameters within the human body, offering real-time insights [more…]